Exploring the Ability of Novel Choroidal Biomarkers in Predicting Treatment Outcomes of Polypoidal Choroidal Vasculopathy
A higher three-dimensional CVI using SS-OCTA is a promising biomarker to predict the poor anatomical response to anti-VEGF treatment in PCV patients.
Authors
- Xiaoya Gu
- Jianing Wang (ORCID: https://orcid.org/0000-0002-9294-2809)
- Jing Liu (ORCID: https://orcid.org/0000-0002-3588-2969)
- Xiaobing Yu (ORCID: https://orcid.org/0000-0001-6480-6335)
- Shuang Song (ORCID: https://orcid.org/0000-0003-3952-7670)
- Yue Zhang (ORCID: https://orcid.org/0000-0002-7786-0231)
Institutions
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
- Beijing Friendship Hospital (CN)
Publication Details
- Journal
- Ophthalmic Research
- Published
- 2024-09-23
- DOI
- https://doi.org/10.1159/000541572
- Citations
- 3
- Primary Topic
- Retinal Imaging and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.21